The global atopic dermatitis treatment market is on the cusp of remarkable expansion, with projections indicating a surge in ...
Comment by Feb. 17 for your feedback to be reviewed by the guideline development workgroup.
AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...
Arcutis Biotherapeutics is going long with the latest push for its seborrheic dermatitis treatment Zoryve. | Arcutis ...
Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...
As temperatures drop, many people experience dry, red, and itchy skin, a condition that often worsens in winter.
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 16,500 ...
Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results